Skip to content

A New Adaptive Feeding Plan for Newborns

A New Adaptive Feeding Plan for Newborns: Effects on Gut Maturity and Gut Microbiota

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00984230
Enrollment
186
Registered
2009-09-25
Start date
2009-09-30
Completion date
2011-02-28
Last updated
2013-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Nutrition

Keywords

Infant Formula, Gut

Brief summary

The purpose of this clinical trial is to identify the infant formula(s) for which the investigators get the closest gut maturation index compared to the one they get with breastfed babies.

Interventions

OTHERBSF

feeding amount according to individual baby need

OTHERBSF + Lactoferrin + Probiotics

feeding amount according to individual baby need

OTHERBSF + Lactoferrin + Probiotics + OS

feeding amount according to individual baby need

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 3 Days
Healthy volunteers
Yes

Inclusion criteria

* Healthy newborn infant * Full term infant (≥ 37 weeks gestation; \< 42 weeks gestation) * Birth weight from 2500g to 4500g * For the formula-fed groups: babies whose mothers elected not to breastfeed at all * For the breastfed group: babies whose mothers elected to exclusively breastfeed for at least 2 months * Newborn whose parents / caregivers can be expected to comply with the protocol * Study explained and written information given * Informed consent signed

Exclusion criteria

* Mother who had antibiotics in the 7 days preceding delivery * Caesarian section * Multiple birth * Congenital illness or malformation that may affect normal growth * Significant pre-natal and/or post-natal disease * Newborn participating in another clinical trial

Design outcomes

Primary

MeasureTime frame
gut maturation : Specific proteins in stools3rd day, at 1 week, 2 weeks and 1 month of age

Secondary

MeasureTime frame
Growth and gut microbiotaAt 1 month and 2 months

Countries

Austria, France, Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026